Food Allergy Research

Less Than Half of Young People With Anaphylaxis Are Given Epinephrine Before Reaching Hospital

Epinephrine is the only first-line treatment for anaphylaxis, a severe, life-threatening allergic reaction. However, a July 2017 study suggests that most children and young adults receiving emergency care for anaphylaxis are not given epinephrine at the onset of symptoms, when the life-saving medication is most effective. Published in the Annals of Allergy, Asthma and Immunology,… Continue reading Less Than Half of Young People With Anaphylaxis Are Given Epinephrine Before Reaching Hospital

Webinars

Webinar Recording and Recap: Advocacy 101: How to Influence Policies and Improve Lives

In our June 21, 2017 webinar, “Advocacy 101: How to Influence Policies and Improve Lives,” FARE advocacy team members Jen Jobrack (Senior National Director for Advocacy) and Jon Hoffman (Associate Director for Advocacy) share how you can help drive changes that make life safer and simpler for people with food allergies. Jen puts the size… Continue reading Webinar Recording and Recap: Advocacy 101: How to Influence Policies and Improve Lives

Uncategorized

Updated Information about the Mylan EpiPen® Auto-Injector Recall of 3/31/2017

The following updated information about the EpiPen® Auto-Injector Recall of 3/31/2017 has been provided by Mylan. If you use EpiPen® Auto-Injector as your epinephrine auto-injector, please follow these steps. STEP 1: Check the lot number on your carton or device to see if your EpiPen® Auto-Injector is affected by the recall. STEP 2: If your EpiPen® Auto-Injector has been recalled,… Continue reading Updated Information about the Mylan EpiPen® Auto-Injector Recall of 3/31/2017

FARE News

2017 Patient Assistance Resources for Epinephrine Auto-Injectors

If you have been prescribed epinephrine, FARE recommends that you carry two epinephrine auto-injectors with you at all times to make sure you have quick access to this life-saving medication. When AUVI-Q® returns to the market on Feb. 14, 2017, there will be four epinephrine auto-injectors available, each with its own pricing structure and programs… Continue reading 2017 Patient Assistance Resources for Epinephrine Auto-Injectors

Webinars

Webinar Recording and Recap: When Should I Use Epi? Why Am I Afraid of It?

The Dec. 12, 2016 webinar –When Should I Use Epi? Why Am I Afraid of It? –featured Jonathan Spergel, MD PhD. Dr. Spergel is Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine. At Children’s Hospital of Philadelphia, he is Chief of the Allergy Section and Director of Center for Pediatric Eosinophilic… Continue reading Webinar Recording and Recap: When Should I Use Epi? Why Am I Afraid of It?

advocacy

Making the Case for Stock Epinephrine in Your School and Community

With legislation allowing undesignated epinephrine in schools and public places continuing to have momentum throughout the country, FARE has created two toolkits to help families advocate for inclusion of stock epinephrine in their communities. Advocating for Undesignated Stock Epinephrine in Your School offers talking points, a frequently asked questions section and background on epinephrine in… Continue reading Making the Case for Stock Epinephrine in Your School and Community

FARE News

2016 Patient Assistance Resources for Epinephrine Auto-Injectors

If you have been prescribed epinephrine, FARE recommends that you carry two epinephrine auto-injectors with you at all times to make sure you have quick access to this life-saving medication. It’s also important to replace any expired auto-injectors right away so that you always have an up-to-date device. We know prescription costs can add up,… Continue reading 2016 Patient Assistance Resources for Epinephrine Auto-Injectors